KPMA chairman calls for fair drug pricing policy

Kim Chung-soo of the Korea Pharmaceutical Manufacturers Association (KPMA) said in a statement that the government should work out measures to encourage drug companies to develop and market as many new drugs as possible to reduce drug costs covered by National Health Insurance.

He said that local pharmaceutical firms have created only 17 drugs. This sharply contrasts to U.S. players that com...